ReviewDrug delivery and translational research2026

Overcoming the oral delivery challenges of venetoclax: advancing a clinically improved Bcl-2 inhibitor.

Yukta Hegishte et al.PubMed ↗Publisher ↗

No numbers read from the abstract.